Update on Developing Myeloma Treatments

Published on

Topics include: Treatments

What’s the latest news in multiple myeloma care? Renowned expert Dr. Elisabet Manasanch, from The University of Texas MD Anderson Cancer Center, discusses a recent FDA approval of a first-in-class drug for the treatment of myeloma. Dr. Manasanch also provides insight to other therapies in the pipeline for myeloma and progress updates from ongoing clinical trials.Watch now to learn more from a multiple myeloma specialist.

This town hall meeting is sponsored by Janssen Biotech, Inc. and Karyopharm Therapeutics with additional support to our partner, Myeloma Crowd (MCR), from Takeda Oncology and Foundation Medicine. These organizations have no editorial control, and Patient Power is solely responsible for the content. It is produced by Patient Power in partnership with The University of Texas MD Anderson Cancer Center.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring and

Produced in association with Myeloma Crowd

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on October 7, 2019